Skip to content
★ Sign in to follow
Total declarations
80
Companies
2
▲ Purchases (1 ops.)
€29k
▼ Sales (7 ops.)
€389k

Latest filing published 30 Jul 2019 for Anika Therapeutics, Inc., €108k.

Filing timeline

BuySale
Joseph G. Darling

Insider track record

Disclosed buys
1
Disclosed sells
7
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Joseph G. Darling: trading record in brief

Joseph G. Darling is a declared insider at 2 companies; the most frequent names are CONMED Corp and Anika Therapeutics, Inc. We count 80 filings; the first trade dates from 1 June 2009 and the latest from 27 July 2019.

Both buying and selling appear: 1 purchase worth €29k, against 7 sales worth €389k. Taken together, the sales exceed the purchases by €359k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 41 share grants and 30 option exercises. In 2019 alone, the filings show 1 purchase and no sales.

The record was last updated on 30 July 2019 with a share grant (€108k) in Anika Therapeutics, Inc. The latest purchase dates back some time: it was published 2,809 days ago, on 1 March 2019. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Joseph G. Darling

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations66 total
  • ◆
    President and CEO; DirectorExecutivesAnika Therapeutics, Inc.
    119,910 USD32SEC
    2,147 shares@ US$55.8578.7% of flowCommon StockSEC:0001171843-19-004978:0
  • ▲
    President and CEO; DirectorExecutivesAnika Therapeutics, Inc.
    33,200 USD24SEC
    1,000 shares@ US$33.2021.3% of flowCommon StockSEC:0001171843-19-001414:0
    Canonical exit: 29 May 2019 (T+90)
  • ◆
    President and CEO; DirectorExecutivesAnika Therapeutics, Inc.
    0SEC
    7,478 shares0Common StockSEC:0001171843-18-001902:0
  • ◆
    President and CEO; DirectorExecutivesAnika Therapeutics, Inc.
    29,313 USD23SEC
    548 shares@ US$53.4914.8% of flowCommon StockSEC:0001171843-18-001902:1
  • ◆
    PresidentExecutivesAnika Therapeutics, Inc.
    0SEC
    14,506 shares0Common StockSEC:0001171843-17-004467:0
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    266,900 USD0SEC
    10,000 shares@ US$26.69Common StockSEC:0001127602-15-003848:0
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    329,830 USD0SEC
    6,893 shares@ US$47.85Common StockSEC:0001127602-15-003848:1
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    104,360 USD0SEC
    4,000 shares@ US$26.09Common StockSEC:0001127602-15-003848:2
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    130,248 USD0SEC
    2,722 shares@ US$47.85Common StockSEC:0001127602-15-003848:3
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    65,860 USD0SEC
    2,000 shares@ US$32.93Common StockSEC:0001127602-15-003848:4
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    74,790 USD0SEC
    1,563 shares@ US$47.85Common StockSEC:0001127602-15-003848:5
  • ▼
    EVP, Commercial OperationsExecutivesCONMED Corp
    2,941 USD0SEC
    70 shares@ US$42.02Common StockSEC:0001127602-14-032958:0
  • ▼
    EVP, Commercial OperationsExecutivesCONMED Corp
    176,400 USD0SEC
    4,200 shares@ US$42.00Common StockSEC:0001127602-14-032958:1
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    164,600 USD0SEC
    10,000 shares@ US$16.46Common StockSEC:0001127602-14-032666:0
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    240,431 USD0SEC
    5,730 shares@ US$41.96Common StockSEC:0001127602-14-032666:1
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    10,686 USD0SEC
    238 shares@ US$44.90Common StockSEC:0001127602-14-020768:0
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    28,063 USD0SEC
    625 shares@ US$44.90Common StockSEC:0001127602-14-020768:3
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    26,716 USD0SEC
    595 shares@ US$44.90Common StockSEC:0001127602-14-020768:6
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    0SEC
    800 shares0Common StockSEC:0001127602-14-019719:0
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    9,519 USD0SEC
    212 shares@ US$44.90Common StockSEC:0001127602-14-019719:1
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    0SEC
    800 shares0Common StockSEC:0001127602-14-019719:2
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    0SEC
    800 shares0Common StockSEC:0001127602-14-019719:4
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    0SEC
    2,000 shares0Common StockSEC:0001127602-14-019719:6
  • ◆
    EVP, Commercial OperationsExecutivesCONMED Corp
    23,752 USD0SEC
    529 shares@ US$44.90Common StockSEC:0001127602-14-019719:7
  • ◇
    EVP, Commercial OperationsExecutivesCONMED Corp
    0SEC
    2,100 shares0Common StockSEC:0001127602-14-019719:8

25 of 66 declarations